Antiphospholipid antibodies as a potential factor of tumor progression

Antiphospholipid antibodies as a potential factor of tumor progression

Introduction. Current generally accepted clinical and laboratory criteria for antiphospholipid syndrome (APS) have been clearly determined, which include vascular thrombosis and pregnancy complications in patients with circulating antiphospholipid antibodies (aPLs). However, in the last several year...

Full description

Saved in:
Bibliographic Details
Main Authors: Z. D. Aslanova, J. Kh. Khizroeva, A. G. Solopova, V. O. Bitsadze, A. V. Vorobev, J.-C. Gris, I. Elalamy, N. A. Makatsariya, D. Yu. Zabolotnaya
Format: Article
Language:Russian
Published: IRBIS LLC 2024-03-01
Series:Акушерство, гинекология и репродукция
Subjects:
antiphospholipid antibodies
apls
cancer
cancer-associated thrombosis
anti-cardiolipin antibodies
acls
anti-β<sub>2</sub>-glycoprotein 1 antibodies
anti-β<sub>2</sub>-gр1
tumor progression
Online Access:https://www.gynecology.su/jour/article/view/1890
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.gynecology.su/jour/article/view/1890

Similar Items